An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis

Dr. Nickolaos Papanickolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Danielle Regge
(Clinical Manager)

Project information


Duration: 01/10/2020-30/09/2024 (48 months)
Total Budget: 9.997.870 €
Topic: DT-TDS-05-2020: AI for Health Imaging
Funded: This project has received funding from the European Union’s Horizon 2020 research and innovation programme
Grant Agreement Nr.: 952159


Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

"Any dataset of radiological images must be assembled by the participation of expert radiologists; there is no radiology without radiologists" Great quote by @HamidRTizhoosh in from @ESR_Journals
How can we bring the Radiologists to the AI space?

Arranca un estudio de investigación sobre los beneficios del remo en #pacientes con #cáncer de mama promovido por el Servicio de #Oncología Médica de Quirónsalud Sagrado Corazón-Oncoavanze

United in Diversity: Thoughts on the Future of 'AI made in Europe' will be next wednesday's @AI4EU Café theme☕️
Join us in this talk about the importance of #AI for our society led by Holger Hoos, professor of Machine Learning at @UniLeiden:

This video shows WHY prostate multi-parametric (mp)MRI should be used, WHICH are the components, WHAT it shows, and HOW to perform PI-RADS v2.1 interpretation.
#mpMRI #prostateMRI #MRIFirst #PIRADS

We've opened registration for 'The Wizardry of #ArtificialIntelligence 2.0: #AI and #MachineLearning in #CancerImaging

This online meeting takes place from 22-24 July 2021. Registration fees are just £65 for all 3 days. 12 CPD points awarded.

Load More...

Stay in touch!